Vito J. Palombella
Net Worth
Last updated:
What is Vito J. Palombella net worth?
The estimated net worth of Dr. Vito J. Palombella is at least $2,858,299 as of 3 Aug 2022. He has earned $168,259 from insider trading and has received compensation worth at least $2,690,040 in Surface Oncology, Inc..
What is the salary of Vito J. Palombella?
Dr. Vito J. Palombella salary is $672,510 per year as Chief Scientific Officer in Surface Oncology, Inc..
How old is Vito J. Palombella?
Dr. Vito J. Palombella is 62 years old, born in 1963.
What stocks does Vito J. Palombella currently own?
As insider, Dr. Vito J. Palombella owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Surface Oncology, Inc. (SURF) | Chief Scientific Officer | 87,212 | $0 | $0 |
What does Surface Oncology, Inc. do?
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibody that inhibits CD39 enzymatic activity for the production of adenosine and the breakdown of adenosine triphosphate; SRF388 targeting interleukin 27; GSK4381562, an antibody targeting CD112R, an inhibitory protein expressed on natural killer and T cells; and SRF114 targeting the chemokine receptor CCR8. Surface Oncology, Inc. has a license agreement with GlaxoSmithKline Intellectual Property (No. 4) Limited to develop, manufacture, and commercialize antibodies that targets SRF813; and license agreement with Vaccinex, Inc. to develop, manufacture, and commercialize antibodies, which targets SRF114. The company was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Vito J. Palombella insider trading
Surface Oncology, Inc.
Dr. Vito J. Palombella has made 2 insider trades between 2021-2022, according to the Form 4 filled with the SEC. Most recently he sold 4,463 units of SURF stock worth $7,676 on 3 Aug 2022.
The largest trade he's ever made was exercising 26,325 units of SURF stock on 21 Jul 2021. As of 3 Aug 2022 he still owns at least 87,212 units of SURF stock.
Surface Oncology key executives
Surface Oncology, Inc. executives and other stock owners filed with the SEC:
- Dr. Robert W. Ross M.D. (51) Pres, Chief Executive Officer & Director
- Dr. Vito J. Palombella (62) Chief Scientific Officer